Clinical Trials Logo

Abdominal Neoplasms clinical trials

View clinical trials related to Abdominal Neoplasms.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06301789 Not yet recruiting - Clinical trials for QLB in Lower Abdominal Cancer Surgeries as a Post Operative Analgesia

Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries

Start date: April 2024
Phase: N/A
Study type: Interventional

The aim of this study is to assess the efficacy of Mg sulfate ( 10% ) as an adjuvant to Bupivacain ( 0.25 % ) in an U.S guided QLB for postoperative analgesia and postoperative Morphine consumption in lower abdominal cancer surgeries.

NCT ID: NCT06276738 Not yet recruiting - Pancreatic Cancer Clinical Trials

The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

Start date: June 30, 2024
Phase:
Study type: Observational [Patient Registry]

Evaluate LINFU® in patients who exhibit signs or symptoms (i.e. jaundice, abdominal pain, weight loss, nausea and vomiting etc.) suggestive of pancreatic cancer (PDAC) or have evidence of imaging studies suggestive of PDAC.

NCT ID: NCT06265948 Not yet recruiting - Abdominal Cancer Clinical Trials

Comparsion Between Intravenous Infusion of Ketofol and Inhalational Anasthetics in Abdominal Cancer Surgeries for Post Operative Analgesia

Start date: March 2024
Phase:
Study type: Observational

( post operative pain between intravenous infusion ketofol and standard inhalational general anesthesia in abdominal cancer surgeries )

NCT ID: NCT06212570 Not yet recruiting - Abdominal Neoplasm Clinical Trials

KeyScope Study in Uganda

Start date: January 1, 2025
Phase: N/A
Study type: Interventional

KeyScope and KeyLoop (collectively called KeySuite) are laparoscopic prototypes that the investigators have designed for the resources, needs and challenges of low- and middle- income countries (LMICs). KeyScope is a laparoscope that plugs into a laptop computer to display images during surgery. It links to a telementoring application so that experienced surgeons can mentor surgeons in capacity-building partnerships. KeyLoop is a laparoscopic retractor that lifts the abdominal wall during surgery, obviating the need for a constant power supply and medical-grade carbon dioxide. The investigators will perform a clinical First-in-Human study at the Uganda Cancer Institute. Ugandan surgeons will use the KeySuite devices to perform biopsies of intra-abdominal tumors.

NCT ID: NCT03169439 Not yet recruiting - Oncology Clinical Trials

Irreversible Electroporation for Treatment of Solid Abdominal Tumors

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Irreversible electroporation (IRE) is a novel non-thermal ablation modality with promise for revolutionizing the treatment for local solid tumors. With the growing demand for alternative and less invasive treatments for localized tumors, the investigators have seen the development and investigation of several tissue ablation modalities, including radiofrequency ablation (RFA), microwave ablation, and cryoablation. Although these modalities have been efficacious, they have some disadvantages owing to their reliance on thermal energy for creating cell death.